Search
Nyxoah SA
NYXHAdd to Watchlist
1.720USD
-0.060-3.37%
Market hours （ET）Quotes delayed by 15 min
74.01MMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-3.37%
5 Days
+6.17%
1 Month
-43.05%
6 Months
-62.61%
Year to Date
-62.61%
1 Year
-77.22%
Key Figures
1.740Open
1.800High
43.60KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.10%Turnover Ratio
1.780Prev. Close
1.705Low
43.33KTurnover
LossP/E Static
1.76P/B
0.00%Div Yield TTM
-71.64%ROA
8.87052wk High
0.86Volume Ratio
-59.24MNet Profit
43.03MShares
-1.8480EPS TTM
0.98Beta
-129.97%ROE
2.30052wk Low
5.33%Amplitude
57.09%Gross Margin
74.01MMarket Cap
-10.75Reward/Risk
3.73%Risk Rate
TradingKey Stock Score of Nyxoah SA
Currency: USD Updated: 2026-07-01Key Insights
Nyxoah SA's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 90 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 8.50.In the medium term, the stock price is expected to trend down.Despite a very weak market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Nyxoah SA's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Nyxoah SA Highlights
StrengthsRisks
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 189.88% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 11.61M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 11.61M.
Overvalued
The company’s latest PE is -0.96, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 9.38M shares, decreasing 8.08% quarter-over-quarter.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 6.06.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
8.500
Target Price
+402.96%
Upside Space
Nyxoah SA News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Nyxoah SA Info
Nyxoah SA is a Belgium-based company that produces medical equipment. The company focuses on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The system consists of a neurostimulator, which is implanted close to the nerve of the tongue, as well as an activation chip, which is connected to a disposable patch and is positioned every night by the patient under the chin.
Ticker SymbolNYXH
CompanyNyxoah SA
CEOTaelman (Olivier)
Websitehttps://www.nyxoah.com/
Related Instruments
-0.17%
+2.26%
+3.56%
+4.87%
+2.00%
-0.80%
+4.37%
+4.20%
+0.30%
+5.11%
+1.76%
+5.91%
+1.39%
+2.24%
-2.42%
+2.55%
+2.73%
-0.66%
-0.34%
-0.57%Popular Instruments
52656.900
+402.600 (+0.77%)
29246.800
-552.500 (-1.85%)
7454.600
-20.900 (-0.28%)
14744.000
-611.000 (-3.98%)
67864.000
-1621.000 (-2.33%)
6348.800
+73.400 (+1.17%)
68.074
+0.106 (+0.16%)
308.270
+13.890 (+4.72%)
193.520
-4.060 (-2.05%)
4116.370
+85.600 (+2.12%)
FAQs
What is the current price of Nyxoah SA (NYXH)?
The current price of Nyxoah SA (NYXH) is 1.78.
What is the symbol of Nyxoah SA?
The ticker symbol of Nyxoah SA is NYXH.
What is the 52-week high of Nyxoah SA?
The 52-week high of Nyxoah SA is 8.87.
What is the 52-week low of Nyxoah SA?
The 52-week low of Nyxoah SA is 2.30.
What is the market capitalization of Nyxoah SA?
The market capitalization of Nyxoah SA is 180.52M.
Is Nyxoah SA (NYXH) currently rated as Buy, Hold, or Sell?
According to analysts, Nyxoah SA (NYXH) has an overall rating of Buy, with a price target of 8.50.
What is the Earnings Per Share (EPS TTM) of Nyxoah SA (NYXH)?
The Earnings Per Share (EPS TTM) of Nyxoah SA (NYXH) is -2.78.